John Montalbano, director of Eupraxia Pharmaceuticals Inc. (TSX:EPRX), picked up 22,000 Common Shares at an average of $6.82 — a $150K buy on Aug 19, 2026.
The purchase grows their position by 1.4%. They still hold 1,558,139 shares — a stake worth roughly $15.1M at today's price.
EPRX shares are trading around $9.72, up 2.3% in the latest session, up 11% over the past three months, and down 7% this year. The stock has ranged from $6.94 to $12.50 over the past 52 weeks.
Insiders sell for a hundred reasons, but they only buy for one — they think it's going higher.
